Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
16,869,505
-
Total 13F shares
-
1,824,779
-
Share change
-
+199,817
-
Total reported value
-
$5,655,903
-
Price per share
-
$3.10
-
Number of holders
-
27
-
Value change
-
+$1,085,798
-
Number of buys
-
10
-
Number of sells
-
11
Institutional Holders of Marker Therapeutics, Inc. - Common Stock, par value $0.001 per share (MRKR) as of Q2 2023
As of 30 Jun 2023,
Marker Therapeutics, Inc. - Common Stock, par value $0.001 per share (MRKR) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,824,779 shares.
The largest 10 holders included
NEA Management Company, LLC, Aisling Capital Management LP, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, WEDBUSH SECURITIES INC, MATRIX ASSET ADVISORS INC/NY, RENAISSANCE TECHNOLOGIES LLC, Virtu Financial LLC, STATE STREET CORP, and Creative Planning.
This page lists
27
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.